Protocatechuic acid attenuate depressive-like behavior in olfactory bulbectomized rat model: behavioral and neurobiochemical investigations.
Vishnu N ThakareRajesh R PatilAnupama A SuralkarValmik D DhakaneBhoomika M PatelPublished in: Metabolic brain disease (2019)
The main objective of the present study is to investigate potential effects of PCA in OBX induced depressive-like behavior in rat model. PCA was administered at a dose of 100 mg/kg and 200 mg/kg, by per oral in OBX and sham operated rats. Behavioral (ambulatory and rearing activity and immobility time), neurochemical [serotonin (5-HT), dopamine (DA), norepinephrine (NE) and brain derived neurotrophic factor (BDNF) expression], biochemical (MDA formation, IL-6, TNF-α and antioxidants) changes in hippocampus and cerebral cortex along with serum corticosterone were investigated. Experimental findings reveals that OBX subjected rats showed alteration in behaviors like, increase in immobility time, ambulatory and rearing behaviors significantly, reduced BDNF level, 5-HT, DA,NE and antioxidant parameters along with increased serum corticosterone, MDA formation, IL-6, and TNF-α in hippocampus and cerebral cortex compared to sham operated rats. Administration of PCA significantly attenuated behavioral and neurobiochemical alterations, thus, its antidepressant-like activity is largely mediated through modulation of neurotransmitter, endocrine and immunologic systems, mainly by improvements of BDNF, 5-HT, DA, NE, reduced MDA, IL-6, and TNF-α in hippocampus and cerebral cortex.
Keyphrases
- cerebral ischemia
- stress induced
- subarachnoid hemorrhage
- rheumatoid arthritis
- breast cancer cells
- functional connectivity
- blood pressure
- prefrontal cortex
- bipolar disorder
- oxidative stress
- brain injury
- poor prognosis
- major depressive disorder
- cell cycle arrest
- blood brain barrier
- diabetic rats
- signaling pathway
- high resolution
- cerebral blood flow
- cell proliferation
- mass spectrometry
- cell death
- human health
- pi k akt